Financial statements Biopharmacotech
Balance sheet of Biopharmacotech
Company age:
Age:
3 y. 10 m. 6 d.
Share capital:
Share capital:
10 000 PLN
Balance sheet data of BIOPHARMACOTECH
|
Year
|
2021
|
2022
|
|---|---|---|
| Total assets | 31 691 891,79 | 31 295 330,84 |
| A. Fixed assets | 610 273,53 | 961 599,48 |
| B. Current assets | 31 081 618,26 | 30 333 731,36 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 31 691 891,79 | 31 295 330,84 |
| A. Equity | 6 691 497,30 | 8 779 260,45 |
| B. Liabilities and provisions for liabilities | 25 000 394,49 | 22 516 070,39 |
| I. Long-term liabilities | 1 340 882,29 | 232 924,12 |
| II. Short-term liabilities | 23 659 512,20 | 22 283 146,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.